每經AI快訊，11月(yue)5日(ri)，北(bei)京(jing)海關(guan)介(jie)紹，進(jin)口(kou)抗癌藥(yao)(yao)索米妥昔單抗注(zhu)射液（商品(pin)名：愛拉(la)赫）已通(tong)(tong)(tong)關(guan)進(jin)京(jing)，并(bing)于第一時(shi)間抵達患者手中(zhong)。據悉(xi)，該(gai)藥(yao)(yao)品(pin)為首批引入國內的卵(luan)巢(chao)癌治(zhi)療新藥(yao)(yao)，該(gai)藥(yao)(yao)品(pin)此次(ci)通(tong)(tong)(tong)關(guan)也意(yi)味著打通(tong)(tong)(tong)了進(jin)口(kou)流通(tong)(tong)(tong)環節的全(quan)鏈(lian)條，即(ji)將(jiang)邁(mai)入全(quan)國性供應保障(zhang)階(jie)段。（北(bei)京(jing)日(ri)報） ???